Home
About HISUN
Company profile
Video
Developing history
Company Achievements
PLA resin
Introduction of PLA resin
Grade list
Certificates
Applications
3D printing
Extrusion, thermoforming
Extrusion and injection blow molding
Film and laminating
Non-woven fabric
Injection molding
News
Information disclosure
Media report
Procurement
Social responsibility
Quality policy
Public welfare activities
Staff style
Contact us
Q&A
Downloads
Join us
Contact information
En
中
Ja
Es
De
It
2026
Phase I (75kt/a) of subsidiary Hitrend's 150kt/a PLA project was officially commissioned in May 2026.
See more
➜
2023
Phase II (20kt/a) of subsidiary Honor's 50kt/a PLA project was commissioned in 2023.
2022
Hisun Biomaterials was listed in SSE STAR MARKET(stock code: 688203) .
2020
Phase I (30kt/a) of subsidiary Honor's 50kt/a PLA project was commissioned in December.
2015
Build a polylactic acid production line with an annual output of 10,000 tons and a processing and modification production line for related products.
2008
5,000 tons/year PLA production line was completed and achieved stable production, which laid foundation for the 10,000-ton polylactic acid production line.
2004
30 tons/year PLA trial facility was built and put into operation, and small-scale production process chain of PLA has been preliminarily mastered.
Zhejiang Hisun Biomaterials Co., Ltd. was established.